The mission of Pratt Institute’s Human Research Subjects Committee / Institutional Review Board (IRB) is to ensure quality research involving human subjects conducted under the auspices of the ...

RALEIGH, N.C.--(BUSINESS WIRE)--Univo IRB, a leader in ethical review and oversight for clinical research, is proud to announce the launch of its Canadian research ethics board (REB) review services.

Leaders across higher education and industry must ensure that their teams and partners think critically about anonymization, ...

Due to the involved nature of the IRB review process, submitting research projects for review can prove to be challenging. In order to simplify the process and support investigators, the IRB has ...

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a presumptive diagnosis of chronic babesiosis in outpatient ...

Ainos (AIMD) has received Institutional Review Board approval from Shuang Ho Hospital, affiliated with Taipei Medical University, for its clinical trial of VELDONA in treating Sjogren’s syndrome.

60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine, marketed as ...

Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or ...

Occasionally, protocols require investigators or other institutions to rely on one another to perform an IRB review. Please see this guidance if wanting more information about Individual Investigator ...

ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan ...

New Release of Advarra's Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site Activation Milestones and IRB Review Status Across Sites COLUMBIA, Md., April ...

OCALA, Fla., April 04, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple ...